{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:35:46Z","timestamp":1761489346292},"reference-count":35,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Blood collected with an anticoagulant is beneficial for simultaneous evaluation of immune cells and humoral components such as antibodies. However, it is critical that the anticoagulant does not affect quantitative and qualitative analyses of antibodies. In the present study, we examined the potential interference of the widely used anticoagulants heparin, EDTA, and acid citrate dextrose (ACD) on vibriocidal antibody activities and\n            <jats:named-content content-type=\"genus-species\">Vibrio cholerae<\/jats:named-content>\n            lipopolysaccharide (LPS)-specific IgG, IgM, and IgA levels in the plasma and sera obtained from cholera patients or vaccinees. Serum vibriocidal antibody titer was inhibited in the presence of EDTA or ACD but not in the presence of heparin. Moreover, 100% (8\/8) of the vibriocidal antibody titers of plasma samples obtained from the vaccinees in tubes containing heparin were identical to the titers of matched sera when compared with 37.5% (3\/8) and 50% (4\/8) of the plasma samples prepared with EDTA and ACD, respectively. Among LPS-specific Igs, the Pearson correlation coefficient (\n            <jats:italic>r<\/jats:italic>\n            ) for IgA in serum and plasma was low (\n            <jats:italic>r<\/jats:italic>\n            = 0.716), and the coefficients for IgG and IgM were relatively high (\n            <jats:italic>r<\/jats:italic>\n            = 0.997 and\n            <jats:italic>r<\/jats:italic>\n            = 0.945, respectively) in heparinized plasma samples compared with the coefficient for IgG and IgM of EDTA- and ACD-treated plasma. Our results suggest that heparin is an appropriate anticoagulant for the collection of blood when measuring vibriocidal activities and antibody levels in plasma samples.\n          <\/jats:p>","DOI":"10.1128\/cvi.00012-14","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T03:27:57Z","timestamp":1397100477000},"page":"854-858","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of Anticoagulants for Serologic Assays of Cholera Vaccination"],"prefix":"10.1128","volume":"21","author":[{"given":"Jae Seung","family":"Yang","sequence":"first","affiliation":[{"name":"Clinical Immunology Section, Laboratory Sciences Division, International Vaccine Institute, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Seong","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Oral Microbiology and Immunology, DRI, and BK21 Plus Program, School of Dentistry, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-Heui","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hyun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Oral Microbiology and Immunology, DRI, and BK21 Plus Program, School of Dentistry, Seoul National University, Seoul, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.6.884"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4757-9688-9_14","volume-title":"Cholera","author":"Levine MM","year":"1992","unstructured":"LevineMMPierceNF. 1992. Immunity and vaccine development, p 285\u2013327. In BaruaDGreenoughWBIII (ed), Cholera. Plenum Medical Book Company, New York, NY."},{"key":"e_1_3_2_4_2","first-page":"777","article-title":"The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients","volume":"38","author":"Mosley WH","year":"1968","unstructured":"MosleyWHAhmadSBenensonASAhmedA. 1968. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bull. World Health Organ. 38:777\u2013785.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.2.236"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.1.79"},{"key":"e_1_3_2_7_2","first-page":"327","article-title":"A serological survey for cholera antibodies in rural east Pakistan. I. The distribution of antibody in the control population of a cholera vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera","volume":"38","author":"Mosley WH","year":"1968","unstructured":"MosleyWHBenensonASBaruiR. 1968. A serological survey for cholera antibodies in rural east Pakistan. I. The distribution of antibody in the control population of a cholera vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera. Bull. World Health Organ. 38:327\u2013334.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/421275"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0195-5616(88)50003-7","article-title":"An overview of hemostasis","volume":"18","author":"Troy GC","year":"1988","unstructured":"TroyGC. 1988. An overview of hemostasis. Vet. Clin. North Am. Small Anim. Pract. 18:5\u201320.","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.11.001"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(02)00183-4"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.145.3638.1310"},{"key":"e_1_3_2_13_2","first-page":"484","article-title":"Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation","volume":"73","author":"Mollnes TE","year":"1988","unstructured":"MollnesTEGarredPBergsethG. 1988. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin. Exp. Immunol. 73:484\u2013488.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1121"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0019-2791(76)90202-0","article-title":"Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement-III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions","volume":"13","author":"Loos M","year":"1976","unstructured":"LoosMVolanakisJEStroudRM. 1976. Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement-III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. Immunochemistry 13:789\u2013791.","journal-title":"Immunochemistry"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.147.2.409"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.2001.01305.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2007.08.009"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2012.121"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-39-3-385"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.49.1.1-32.1985"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.56.3.395-411.1992"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.12.2189"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.11.2.273-279.1975"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408369509084686"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0898-6568(93)90019-I"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0915162107"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0311"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(86)90100-2"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00385-07"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.11.014"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00325-10"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100075805"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200500535"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.040303"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00607-13"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00012-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00012-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:50:32Z","timestamp":1627591832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00012-14"}},"subtitle":[],"editor":[{"given":"V. M.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1128\/CVI.00012-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00012-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"2014-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}